Kevin O’Neill

Kevin O’Neill is President and CEO of GE Healthcare Pharmaceutical Diagnostics, a global leader in contrast media and molecular imaging agents that help improve diagnostic confidence and decision-making, as well as support therapy selection and treatment monitoring.

Kevin is also President & CEO of GE in UK and Ireland, where GE is one of the most significant exporters and employs more than 16,000 people.